Inhibitors targeting enzymes like isocitrate dehydrogenase (IDH) (in mutant GBM), LDH (lactate dehydrogenase), and GLS (glutaminase) are being studied for their potential to starve GBM cells. This evidence concerns the gene IDH3A and glioblastoma.